Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease
- PMID: 6093296
- DOI: 10.1097/00007890-198411000-00004
Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease
Abstract
Of 68 consecutive allogeneic bone marrow transplant patients, 53 survived more than three months after transplantation. Twenty-two (42%) developed chronic graft-versus-host disease (GVHD). Chronic GVHD was more common among patients who had previously experienced cytomegalovirus (CMV) infection (20/36, 56%) than among those without signs of active CMV infection (2/17, 12%) (P less than 0.01). The CMV infections preceded the development of chronic GVHD by a median of 128 days (range 23-322 days). Children below 14 years of age who had had CMV infection developed chronic GVHD as often as older patients (8/14 vs. 12/22). CMV infection may pave the way for chronic GVHD.
Similar articles
-
An analysis of factors predisposing to chronic graft-versus-host disease.Exp Hematol. 1985 Nov;13(10):1062-7. Exp Hematol. 1985. PMID: 2996920
-
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.Bone Marrow Transplant. 1990 Jun;5(6):413-8. Bone Marrow Transplant. 1990. PMID: 2164434
-
Cytomegalovirus infection after marrow transplantation for aplastic anemia.Bone Marrow Transplant. 1990 Nov;6(5):295-300. Bone Marrow Transplant. 1990. PMID: 1963336 Clinical Trial.
-
Early and late interstitial pneumonia following human bone marrow transplantation.Int J Cell Cloning. 1986;4 Suppl 1:107-21. doi: 10.1002/stem.5530040712. Int J Cell Cloning. 1986. PMID: 3018098 Review.
-
Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia.Bone Marrow Transplant. 1993 Sep;12(3):225-31. Bone Marrow Transplant. 1993. PMID: 8241981 Review.
Cited by
-
Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.J Clin Microbiol. 1992 Oct;30(10):2735-9. doi: 10.1128/jcm.30.10.2735-2739.1992. J Clin Microbiol. 1992. PMID: 1328283 Free PMC article.
-
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease.Int J Hematol. 2025 Jan;121(1):110-125. doi: 10.1007/s12185-024-03871-4. Epub 2024 Nov 14. Int J Hematol. 2025. PMID: 39543007
-
Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.Front Immunol. 2018 Apr 10;9:760. doi: 10.3389/fimmu.2018.00760. eCollection 2018. Front Immunol. 2018. PMID: 29692783 Free PMC article.
-
Cytomegalovirus-induced immunopathology and its clinical consequences.Herpesviridae. 2011 Apr 7;2(1):6. doi: 10.1186/2042-4280-2-6. Herpesviridae. 2011. PMID: 21473750 Free PMC article.
-
Cytomegaloviral virus infection in bone marrow transplantation recipients: strategies for prevention and treatment.Support Care Cancer. 1993 Sep;1(5):245-9. doi: 10.1007/BF00366043. Support Care Cancer. 1993. PMID: 8156234 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical